<!DOCTYPE html>
<html lang="cs">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>C√≠len√≠ NSD2 obrac√≠ plasticitu a l√©kovou rezistenci u rakoviny prostaty | Marigold.cz Tech News</title>
    <meta name="description" content="Inhibice histonov√© metyltransfer√°zy NSD2 a androgenov√©ho receptoru v preklinick√Ωch modelech dok√°≈æe obr√°tit liniovou plasticitu, potlaƒçit r≈Øst n√°doru a navr√°tit ">
    <link rel="canonical" href="https://www.marigold.cz/tech-news/2025-11-26/nsd2-targeting-reverses-plasticity-and-drug-resist/">
    <style>
        * { margin: 0; padding: 0; box-sizing: border-box; }
        body { font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, sans-serif; line-height: 1.6; color: #374151; background: #f3f4f6; }
        .container { max-width: 800px; margin: 0 auto; padding: 2rem; }
        .tech-news-article { background: white; border-radius: 12px; box-shadow: 0 4px 6px rgba(0,0,0,0.1); padding: 2rem; margin: 2rem 0; }
        .source-info { display: flex; align-items: center; gap: 0.75rem; margin-bottom: 1rem; flex-wrap: wrap; }
        .source-emoji { font-size: 1.5rem; }
        .source-name { font-weight: 600; color: #374151; }
        .importance-indicator { display: flex; gap: 2px; margin-left: auto; }
        .star { color: #fbbf24; font-size: 1.2rem; }
        .star.empty { color: #d1d5db; }
        .article-title { font-size: 2rem; font-weight: 700; line-height: 1.2; margin-bottom: 1rem; color: #111827; }
        .article-meta { display: flex; align-items: center; gap: 1rem; font-size: 0.875rem; color: #6b7280; margin-bottom: 1.5rem; }
        .category { padding: 0.25rem 0.75rem; border-radius: 1rem; font-weight: 500; font-size: 0.75rem; text-transform: uppercase; background: #e5e7eb; color: #374151; }
        .article-image { margin: 1.5rem 0; border-radius: 8px; overflow: hidden; }
        .article-image img { width: 100%; height: auto; display: block; }
        .article-content { font-size: 1.125rem; line-height: 1.7; margin-bottom: 2rem; }
        .article-content h2 { font-size: 1.5rem; margin: 1.5rem 0 1rem; color: #111827; }
        .article-content p { margin-bottom: 1rem; }
        .article-footer { border-top: 1px solid #e5e7eb; padding-top: 1.5rem; }
        .read-more-btn { display: inline-flex; align-items: center; gap: 0.5rem; padding: 0.75rem 1.5rem; background: #3b82f6; color: white; text-decoration: none; border-radius: 8px; font-weight: 500; }
        .read-more-btn:hover { background: #2563eb; }
        .original-title { margin-top: 1rem; color: #6b7280; font-size: 0.875rem; }
        .back-link { display: inline-block; margin-bottom: 1rem; color: #3b82f6; text-decoration: none; }
        .back-link:hover { text-decoration: underline; }
        .archive-notice { background: #fef3c7; border: 1px solid #f59e0b; border-radius: 8px; padding: 1rem; margin-bottom: 1rem; font-size: 0.875rem; color: #92400e; }
        @media (max-width: 640px) {
            .container { padding: 1rem; }
            .tech-news-article { padding: 1.5rem; margin: 1rem 0; }
            .article-title { font-size: 1.5rem; }
            .source-info { flex-direction: column; align-items: flex-start; }
            .importance-indicator { margin-left: 0; margin-top: 0.5rem; }
        }
    </style>
</head>
<body>
    <div class="container">
        <a href="/tech-news/" class="back-link">&larr; Zpƒõt na Tech News</a>

        <div class="archive-notice">
            Tento ƒçl√°nek je z archivu. Byl publikov√°n 26.11.2025.
        </div>

        <article class="tech-news-article">
            <header>
                <div class="source-info">
                    <span class="source-emoji">üì∞</span>
                    <span class="source-name">Nature.com</span>
                    <div class="importance-indicator">
                        <span class="star">‚òÖ</span><span class="star">‚òÖ</span><span class="star">‚òÖ</span><span class="star empty">‚òÜ</span><span class="star empty">‚òÜ</span>
                    </div>
                </div>

                <h1 class="article-title">C√≠len√≠ NSD2 obrac√≠ plasticitu a l√©kovou rezistenci u rakoviny prostaty</h1>

                <div class="article-meta">
                    <time datetime="2025-11-26T00:00:00+00:00">26.11.2025</time>
                    <span class="category">onkologie</span>
                </div>
            </header>

            
            <div class="article-image">
                <img src="https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41586-025-09727-z/MediaObjects/41586_2025_9727_Fig1_HTML.png" alt="C√≠len√≠ NSD2 obrac√≠ plasticitu a l√©kovou rezistenci u rakoviny prostaty" loading="lazy">
            </div>
        

            <div class="article-content">
                <h2>Souhrn</h2>
<p>V√Ωzkum ukazuje, ≈æe c√≠len√° inhibice enzymu NSD2, kter√Ω modifikuje histony, dok√°≈æe obr√°tit agresivn√≠ fenotyp kastrac√≠ rezistentn√≠ rakoviny prostaty (CRPC) zpƒõt na m√©nƒõ agresivn√≠ adenokarcinom. Tento p≈ô√≠stup obnovuje √∫ƒçinnost l√©ƒçby inhibitory androgenov√©ho receptoru, jako je enzalutamid, a navozuje bunƒõƒçnou smrt v preklinick√Ωch modelech vƒçetnƒõ lidsk√Ωch org√°noid≈Ø a xenotransplant√°t≈Ø.</p>
<h2>Kl√≠ƒçov√© body</h2>
<ul>
<li>NSD2 je histonov√° metyltransfer√°za, jej√≠≈æ zv√Ω≈°en√° exprese koreluje s hor≈°√≠ progn√≥zou u pacient≈Ø s neuroendokrinn√≠m podtypem CRPC (CRPC-NE).</li>
<li>Genetick√° nebo farmakologick√° inhibice NSD2 vede k obnoven√≠ adenokarcinomov√©ho fenotypu a znovuaktivaci programu androgenov√©ho receptoru.</li>
<li>Kombinace inhibitoru NSD2 s enzalutamidem synergicky potlaƒçuje r≈Øst n√°doru a zvy≈°uje apopt√≥zu v org√°noidech odvozen√Ωch od pacient≈Ø.</li>
<li>V√Ωsledky naznaƒçuj√≠ mo≈ænost nov√© terapeutick√© strategie pro l√©ƒçbu dosud nezvl√°dnuteln√Ωch forem CRPC.</li>
</ul>
<h2>Podrobnosti</h2>
<p>Liniov√° plasticita ‚Äì schopnost n√°dorov√Ωch bunƒõk mƒõnit sv≈Øj fenotyp ‚Äì je kl√≠ƒçov√Ωm mechanismem rezistence u CRPC. Tento proces ƒçasto vede k p≈ôemƒõnƒõ adenokarcinomu na agresivn√≠ neuroendokrinn√≠ variantu (CRPC-NE), kter√° neodpov√≠d√° na standardn√≠ terapii zamƒõ≈ôenou na androgenov√Ω receptor (AR). V√Ωzkumn√≠ci identifikovali enzym NSD2 jako centr√°ln√≠ regul√°tor t√©to plasticity prost≈ôednictv√≠m dimetylizace histonu H3 na pozici K36 (H3K36me2), co≈æ ovliv≈àuje enhancery gen≈Ø spojen√Ωch s neuroendokrinn√≠ diferenciac√≠. V org√°noidech z geneticky upraven√Ωch my≈°√≠ i lidsk√Ωch vzork≈Ø CRPC-NE vedlo CRISPRem zprost≈ôedkovan√© vypnut√≠ NSD2 k n√°vratu k adenokarcinomov√©mu stavu a obnoven√≠ exprese AR. Farmakologick√° inhibice NSD2 pomoc√≠ prvn√≠ho mal√© molekuly t√©to t≈ô√≠dy potvrdila tyto efekty in vitro i in vivo. Kombinace s enzalutamidem v√Ωraznƒõ zv√Ω≈°ila √∫ƒçinnost l√©ƒçby.</p>
<h2>Proƒç je to d≈Øle≈æit√©</h2>
<p>Tento objev otev√≠r√° cestu k nov√© t≈ô√≠dƒõ epigenetick√Ωch terapi√≠ pro agresivn√≠ formy rakoviny prostaty, kter√© dnes nemaj√≠ √∫ƒçinnou l√©ƒçbu. Zat√≠mco vƒõt≈°ina epigenetick√Ωch zmƒõn je pova≈æov√°na za trval√©, tento v√Ωzkum ukazuje, ≈æe nƒõkter√© jsou reverzibiln√≠ ‚Äì co≈æ m√° ≈°ir≈°√≠ implikace i pro jin√© typy n√°dor≈Ø. Pokud se farmakologick√© inhibitory NSD2 osvƒõdƒç√≠ v klinick√Ωch studi√≠ch, mohou se st√°t souƒç√°st√≠ kombinovan√© terapie, kter√° by zpomalila nebo dokonce zvr√°tila progresi CRPC.</p>
<hr />
<p><a href="https://www.nature.com/articles/s41586-025-09727-z">ƒå√≠st p≈Øvodn√≠ ƒçl√°nek</a></p>
<p><strong>Zdroj:</strong> üì∞ Nature.com</p>
            </div>

            <footer class="article-footer">
                <a href="https://www.nature.com/articles/s41586-025-09727-z" target="_blank" rel="noopener" class="read-more-btn">
                    ƒå√≠st p≈Øvodn√≠ ƒçl√°nek &rarr;
                </a>

                <div class="original-title"><small>P≈Øvodn√≠ n√°zev: NSD2 targeting reverses plasticity and drug resistance in prostate cancer</small></div>
            </footer>
        </article>

        <p style="text-align: center; color: #6b7280; font-size: 0.875rem; margin-top: 2rem;">
            &copy; 2025 <a href="https://www.marigold.cz" style="color: #3b82f6;">Marigold.cz</a>
        </p>
    </div>
</body>
</html>
